Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07728383 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Proof-of-Concept Study to Evaluate Topical-Lingual Semaglutide in Adults With Obesity

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This study investigates the Topical-Lingual (T-L) delivery of semaglutide, a GLP-1 receptor agonist (GLP-1RA), via an oral liquid emulsion formulation as a Proof-of-Concept for the T-L delivery of metabolic hormones in general. GLP-1 is a gut-derived hormone that induces satiation through hypothalamic pathways.
Trial Details
NCT Number NCT07728383
Lead Sponsor Gila Therapeutics, Inc.
Conditions
(from sponsor)		 Obesity & Overweight
Related terms Obesity, Overweight
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov